Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Yi Larson Insider Profile
11 Followers
Yi Larson, EVP & CFO at Turning Point Therapeutics, holds 2.70K shares in Turning Point Therapeutics (Ticker: TPTX), holds ― shares in Olema Pharmaceuticals (Ticker: OLMA), holds 325.90K shares in LianBio Sponsored ADR (Ticker: LIANY). Most recently, Yi Larson Bought ― shares of Turning Point Therapeutics on Sep 11, 2019 for an estimated value of 99.99K.
Yi Larson Turning Point Therapeutics (TPTX)EVP & CFO
Turning Point Therapeutics (TPTX)
EVP & CFO
Not Ranked
Yi Larson has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Yi Larson holds in companies
Most Profitable Insider Trade
Stock:
Turning Point Therapeutics
(TPTX)
(TPTX)
Rating:Informative Buy
Date:Sep 11, 2019 - Sep 11, 2020
Return:+57.90%
The most profitable trade made by Yi Larson
Yi Larson's Trading History
Turning Point Therapeutics
Sep 11, 2019
―
Informative Buy
99.99K
$205.53K
Olema Pharmaceuticals
―
Director
―
―
LianBio Sponsored ADR
Mar 31, 2023
CFO
Uninformative Buy
―
$97.77K
RayzeBio, Inc.
―
―
―
―
List of latest transactions for each holding click on a transaction to see Yi Larson's performance on stock
You May Also Like
Yi Larson insider profile FAQ
What is the percentage of profitable transactions made by Yi Larson?
The percentage of profitable transactions made by Yi Larson is ―.
What is the average return per transaction made by Yi Larson?
The average return per transaction made by Yi Larson is ―.
What stocks does Yi Larson hold?
Yi Larson holds: TPTX, OLMA, LIANY, RYZB stocks.
What was Yi Larson’s latest transaction?
Yi Larson latest transaction was an Informative Buy of $99.99K.
What was Yi Larson's most profitable transaction?
Yi Larson’s most profitable transaction was an Informative Buy of TPTX stock on September 11, 2019. The return on the trade was 57.90%.
What is Yi Larson's role in Turning Point Therapeutics?
Yi Larson's role in Turning Point Therapeutics is EVP & CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.